Blog

Day: April 6, 2023

Blue hued illustration of a DNA strand (double helix)

GID BIO reaches halfway enrollment in cell therapy trial

GID BIO reaches halfway enrollment in randomized double-blinded pivotal Phase III cell therapy trial
FDA-compliant trial addresses treatment gap for regenerative medicine to potentially treat knee osteoarthritis…

error: Content is protected !!
Skip to content